|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1301 to 1400 out of 2570 for Kras

Category restricted to Publication (x)

0.037s

Categories

Category: Publication
Type Details Score
Publication
First Author: Wang D
Year: 2017
Journal: Cancer Res
Title: CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer.
Volume: 77
Issue: 13
Pages: 3655-3665
Publication
First Author: Justilien V
Year: 2017
Journal: Cancer Cell
Title: Ect2-Dependent rRNA Synthesis Is Required for KRAS-TRP53-Driven Lung Adenocarcinoma.
Volume: 31
Issue: 2
Pages: 256-269
Publication
First Author: Crittenden MR
Year: 2018
Journal: Sci Rep
Title: Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity.
Volume: 8
Issue: 1
Pages: 7012
Publication
First Author: Qiao S
Year: 2020
Journal: Genes Dev
Title: REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumors.
Volume: 34
Issue: 11-12
Pages: 751-766
Publication  
First Author: Salaymeh Y
Year: 2020
Journal: Life Sci Alliance
Title: Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice.
Volume: 3
Issue: 5
Publication
First Author: Chugh S
Year: 2018
Journal: Gastroenterology
Title: Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice.
Volume: 155
Issue: 5
Pages: 1608-1624
Publication
First Author: Davidson SM
Year: 2017
Journal: Nat Med
Title: Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors.
Volume: 23
Issue: 2
Pages: 235-241
Publication  
First Author: Verma RK
Year: 2016
Journal: Sci Rep
Title: α-Mangostin-encapsulated PLGA nanoparticles inhibit pancreatic carcinogenesis by targeting cancer stem cells in human, and transgenic (Kras(G12D), and Kras(G12D)/tp53R270H) mice.
Volume: 6
Pages: 32743
Publication  
First Author: Gong L
Year: 2021
Journal: Cancer Lett
Title: DEPTOR inhibits lung tumorigenesis by inactivating the EGFR-mTOR signals.
Volume: 519
Pages: 263-276
Publication
First Author: Faca VM
Year: 2008
Journal: PLoS Med
Title: A mouse to human search for plasma proteome changes associated with pancreatic tumor development.
Volume: 5
Issue: 6
Pages: e123
Publication
First Author: Boj SF
Year: 2015
Journal: Cell
Title: Organoid models of human and mouse ductal pancreatic cancer.
Volume: 160
Issue: 1-2
Pages: 324-38
Publication
First Author: Shin J
Year: 2014
Journal: Cancer Lett
Title: A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
Volume: 342
Issue: 1
Pages: 70-81
Publication
First Author: Frese KK
Year: 2012
Journal: Cancer Discov
Title: nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.
Volume: 2
Issue: 3
Pages: 260-269
Publication
First Author: Dauer P
Year: 2018
Journal: Cancer Res
Title: Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression.
Volume: 78
Issue: 5
Pages: 1321-1333
Publication
First Author: Pietrocola F
Year: 2016
Journal: Cancer Cell
Title: Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance.
Volume: 30
Issue: 1
Pages: 147-160
Publication
First Author: Miller BW
Year: 2015
Journal: EMBO Mol Med
Title: Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy.
Volume: 7
Issue: 8
Pages: 1063-76
Publication
First Author: Kelly-Spratt KS
Year: 2011
Journal: PLoS One
Title: Plasma proteome profiles associated with inflammation, angiogenesis, and cancer.
Volume: 6
Issue: 5
Pages: e19721
Publication
First Author: Leca J
Year: 2016
Journal: J Clin Invest
Title: Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.
Volume: 126
Issue: 11
Pages: 4140-4156
Publication
First Author: Dugnani E
Year: 2018
Journal: Carcinogenesis
Title: Four-class tumor staging for early diagnosis and monitoring of murine pancreatic cancer using magnetic resonance and ultrasound.
Volume: 39
Issue: 9
Pages: 1197-1206
Publication  
First Author: Cortes E
Year: 2019
Journal: EMBO Rep
Title: GPER is a mechanoregulator of pancreatic stellate cells and the tumor microenvironment.
Volume: 20
Issue: 1
Publication
First Author: Kaistha BP
Year: 2016
Journal: Cancer Res
Title: PLAC8 Localizes to the Inner Plasma Membrane of Pancreatic Cancer Cells and Regulates Cell Growth and Disease Progression through Critical Cell-Cycle Regulatory Pathways.
Volume: 76
Issue: 1
Pages: 96-107
Publication
First Author: Filippini D
Year: 2019
Journal: Sci Rep
Title: Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease.
Volume: 9
Issue: 1
Pages: 12286
Publication
First Author: Hein AL
Year: 2016
Journal: Cancer Res
Title: PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling.
Volume: 76
Issue: 8
Pages: 2243-2253
Publication    
First Author: Sullivan MR
Year: 2019
Journal: Elife
Title: Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability.
Volume: 8
Publication
First Author: Zandvakili I
Year: 2015
Journal: PLoS One
Title: Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice.
Volume: 10
Issue: 6
Pages: e0127923
Publication
First Author: Low RRJ
Year: 2023
Journal: Cell Death Differ
Title: S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer.
Volume: 30
Issue: 5
Pages: 1155-1165
Publication
First Author: Xia Y
Year: 2012
Journal: Nat Cell Biol
Title: Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model.
Volume: 14
Issue: 3
Pages: 257-65
Publication
First Author: Lee JC
Year: 2013
Journal: Biochem Biophys Res Commun
Title: Trisomy of the Dscr1 gene suppresses early progression of pancreatic intraepithelial neoplasia driven by oncogenic Kras.
Volume: 440
Issue: 1
Pages: 50-5
Publication
First Author: Dominguez CX
Year: 2020
Journal: Cancer Discov
Title: Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy.
Volume: 10
Issue: 2
Pages: 232-253
Publication
First Author: Öhlund D
Year: 2017
Journal: J Exp Med
Title: Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer.
Volume: 214
Issue: 3
Pages: 579-596
Publication
First Author: Gocheva V
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival.
Volume: 114
Issue: 28
Pages: E5625-E5634
Publication
First Author: Chugh R
Year: 2012
Journal: Sci Transl Med
Title: A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.
Volume: 4
Issue: 156
Pages: 156ra139
Publication
First Author: Raj N
Year: 2022
Journal: Mol Cell
Title: The Mettl3 epitranscriptomic writer amplifies p53 stress responses.
Volume: 82
Issue: 13
Pages: 2370-2384.e10
Publication
First Author: Ischenko I
Year: 2014
Journal: Cell Death Differ
Title: Transforming growth factor-beta signaling network regulates plasticity and lineage commitment of lung cancer cells.
Volume: 21
Issue: 8
Pages: 1218-28
Publication
First Author: Cao S
Year: 2022
Journal: Theranostics
Title: Glutamine is essential for overcoming the immunosuppressive microenvironment in malignant salivary gland tumors.
Volume: 12
Issue: 13
Pages: 6038-6056
Publication
First Author: Merle N
Year: 2022
Journal: Mol Cancer
Title: Monitoring autochthonous lung tumors induced by somatic CRISPR gene editing in mice using a secreted luciferase.
Volume: 21
Issue: 1
Pages: 191
Publication  
First Author: Cortez NE
Year: 2023
Journal: Int J Mol Sci
Title: A Ketogenic Diet in Combination with Gemcitabine Mitigates Pancreatic Cancer-Associated Cachexia in Male and Female KPC Mice.
Volume: 24
Issue: 13
Publication
First Author: Su HT
Year: 2013
Journal: Mol Cancer Res
Title: Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
Volume: 11
Issue: 7
Pages: 768-79
Publication
First Author: Novo D
Year: 2018
Journal: Nat Commun
Title: Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels.
Volume: 9
Issue: 1
Pages: 5069
Publication
First Author: Hu T
Year: 2021
Journal: Gastroenterology
Title: Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression.
Volume: 161
Issue: 5
Pages: 1584-1600
Publication
First Author: Gouirand V
Year: 2022
Journal: EMBO J
Title: Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression.
Volume: 41
Issue: 9
Pages: e110466
Publication
First Author: Ireland L
Year: 2016
Journal: Cancer Res
Title: Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors.
Volume: 76
Issue: 23
Pages: 6851-6863
Publication
First Author: Johnson L
Year: 2013
Journal: J Clin Invest
Title: Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy.
Volume: 123
Issue: 9
Pages: 3997-4009
Publication
First Author: Su Y
Year: 2016
Journal: Oncogene
Title: N-cadherin functions as a growth suppressor in a model of K-ras-induced PanIN.
Volume: 35
Issue: 25
Pages: 3335-41
Publication
First Author: Araki O
Year: 2023
Journal: Oncogene
Title: Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway.
Volume: 42
Issue: 26
Pages: 2139-2152
Publication
First Author: Sanclemente M
Year: 2021
Journal: Cancer Cell
Title: RAF1 kinase activity is dispensable for KRAS/p53 mutant lung tumor progression.
Volume: 39
Issue: 3
Pages: 294-296
Publication
First Author: Liang S
Year: 2009
Journal: PLoS One
Title: Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation.
Volume: 4
Issue: 1
Pages: e4295
Publication
First Author: Du T
Year: 2019
Journal: Nat Commun
Title: The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis.
Volume: 10
Issue: 1
Pages: 2914
Publication      
First Author: Peng F
Year: 2024
Journal: Cell Metab
Title: Oncogenic fatty acid oxidation senses circadian disruption in sleep-deficiency-enhanced tumorigenesis.
Publication
First Author: Nie G
Year: 2024
Journal: Biochim Biophys Acta Gen Subj
Title: DHX33 mediates p53 to regulate mevalonate pathway gene transcription in human cancers.
Volume: 1868
Issue: 3
Pages: 130547
Publication
First Author: Zheng QW
Year: 2022
Journal: Oncogene
Title: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3.
Volume: 41
Issue: 36
Pages: 4244-4256
Publication
First Author: Puranam KL
Year: 1995
Journal: Genomics
Title: Chromosomal localization of the gene encoding the human DNA helicase RECQL and its mouse homologue.
Volume: 26
Issue: 3
Pages: 595-8
Publication
First Author: Muñoz DM
Year: 2013
Journal: Glia
Title: Loss of p53 cooperates with K-ras activation to induce glioma formation in a region-independent manner.
Volume: 61
Issue: 11
Pages: 1862-72
Publication
First Author: Arima K
Year: 2019
Journal: Oncogene
Title: Inhibition of 15-PGDH causes Kras-driven tumor expansion through prostaglandin E2-ALDH1 signaling in the pancreas.
Volume: 38
Issue: 8
Pages: 1211-1224
Publication  
First Author: Hamada S
Year: 2021
Journal: Int J Mol Sci
Title: Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition.
Volume: 22
Issue: 4
Publication
First Author: Best SA
Year: 2020
Journal: Cell Death Dis
Title: Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis.
Volume: 11
Issue: 10
Pages: 877
Publication
First Author: Cho YH
Year: 2016
Journal: Oncotarget
Title: KY1022, a small molecule destabilizing Ras via targeting the Wnt/β-catenin pathway, inhibits development of metastatic colorectal cancer.
Volume: 7
Issue: 49
Pages: 81727-81740
Publication  
First Author: Hartmann O
Year: 2021
Journal: Front Cell Dev Biol
Title: Implementation of CRISPR/Cas9 Genome Editing to Generate Murine Lung Cancer Models That Depict the Mutational Landscape of Human Disease.
Volume: 9
Pages: 641618
Publication
First Author: Lee YS
Year: 2020
Journal: Mol Cells
Title: K-Ras-Activated Cells Can Develop into Lung Tumors When Runx3-Mediated Tumor Suppressor Pathways Are Abrogated.
Volume: 43
Issue: 10
Pages: 889-897
Publication
First Author: Huarte M
Year: 2010
Journal: Cell
Title: A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response.
Volume: 142
Issue: 3
Pages: 409-19
Publication
First Author: Kim E
Year: 1999
Journal: J Biol Chem
Title: Disruption of the mouse Rce1 gene results in defective Ras processing and mislocalization of Ras within cells.
Volume: 274
Issue: 13
Pages: 8383-90
Publication
First Author: Gupta S
Year: 2007
Journal: Cell
Title: Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice.
Volume: 129
Issue: 5
Pages: 957-68
Publication
First Author: Hsu DK
Year: 1996
Journal: J Biol Chem
Title: Identification of a murine TEF-1-related gene expressed after mitogenic stimulation of quiescent fibroblasts and during myogenic differentiation.
Volume: 271
Issue: 23
Pages: 13786-95
Publication
First Author: Xie CM
Year: 2015
Journal: J Cell Biol
Title: Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis.
Volume: 209
Issue: 5
Pages: 721-37
Publication
First Author: Ma Y
Year: 2020
Journal: Gastroenterology
Title: Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer.
Volume: 159
Issue: 1
Pages: 306-319.e12
Publication  
First Author: Satpathy SR
Year: 2015
Journal: Nat Commun
Title: Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth.
Volume: 6
Pages: 7064
Publication
First Author: Floerchinger A
Year: 2021
Journal: Cell Rep
Title: Optimizing metastatic-cascade-dependent Rac1 targeting in breast cancer: Guidance using optical window intravital FRET imaging.
Volume: 36
Issue: 11
Pages: 109689
Publication
First Author: Hoshino A
Year: 2020
Journal: Cell
Title: Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.
Volume: 182
Issue: 4
Pages: 1044-1061.e18
Publication
First Author: Nayak D
Year: 2022
Journal: iScience
Title: EMT alterations in the solute carrier landscape uncover SLC22A10/A15 imposed vulnerabilities in pancreatic cancer.
Volume: 25
Issue: 5
Pages: 104193
Publication
First Author: de Sousa e Melo F
Year: 2017
Journal: Nature
Title: A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer.
Volume: 543
Issue: 7647
Pages: 676-680
Publication
First Author: Cho YH
Year: 2020
Journal: Nat Commun
Title: 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation.
Volume: 11
Issue: 1
Pages: 5321
Publication  
First Author: Enquist IB
Year: 2014
Journal: Nat Commun
Title: Lymph node-independent liver metastasis in a model of metastatic colorectal cancer.
Volume: 5
Pages: 3530
Publication
First Author: Johnson L
Year: 2001
Journal: Nature
Title: Somatic activation of the K-ras oncogene causes early onset lung cancer in mice.
Volume: 410
Issue: 6832
Pages: 1111-6
Publication
First Author: Schmidt S
Year: 2019
Journal: Nat Cell Biol
Title: A MYC-GCN2-eIF2α negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer.
Volume: 21
Issue: 11
Pages: 1413-1424
Publication
First Author: Shen M
Year: 2021
Journal: Cancer Res
Title: Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis.
Volume: 81
Issue: 4
Pages: 1014-1025
Publication    
First Author: Knight JR
Year: 2021
Journal: Elife
Title: Rpl24Bst mutation suppresses colorectal cancer by promoting eEF2 phosphorylation via eEF2K.
Volume: 10
Publication
First Author: Huang Q
Year: 2022
Journal: Cell
Title: The primordial differentiation of tumor-specific memory CD8(+) T cells as bona fide responders to PD-1/PD-L1 blockade in draining lymph nodes.
Volume: 185
Issue: 22
Pages: 4049-4066.e25
Publication
First Author: Alam MS
Year: 2015
Journal: Nat Med
Title: Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression.
Volume: 21
Issue: 11
Pages: 1337-43
Publication
First Author: Khasawneh J
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion.
Volume: 106
Issue: 9
Pages: 3354-9
Publication
First Author: Lee CL
Year: 2021
Journal: Cancer Res
Title: Whole-Exome Sequencing of Radiation-Induced Thymic Lymphoma in Mouse Models Identifies Notch1 Activation as a Driver of p53 Wild-Type Lymphoma.
Volume: 81
Issue: 14
Pages: 3777-3790
Publication
First Author: Gilad O
Year: 2010
Journal: Cancer Res
Title: Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner.
Volume: 70
Issue: 23
Pages: 9693-702
Publication
First Author: Aryal NK
Year: 2019
Journal: Cancer Res
Title: Dicer1 Phosphomimetic Promotes Tumor Progression and Dissemination.
Volume: 79
Issue: 10
Pages: 2662-2668
Publication
First Author: Loeb KR
Year: 2005
Journal: Cancer Cell
Title: A mouse model for cyclin E-dependent genetic instability and tumorigenesis.
Volume: 8
Issue: 1
Pages: 35-47
Publication
First Author: Bastea LI
Year: 2019
Journal: Cancer Res
Title: Pomalidomide Alters Pancreatic Macrophage Populations to Generate an Immune-Responsive Environment at Precancerous and Cancerous Lesions.
Volume: 79
Issue: 7
Pages: 1535-1548
Publication
First Author: De Raedt T
Year: 2011
Journal: Cancer Cell
Title: Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors.
Volume: 20
Issue: 3
Pages: 400-13
Publication
First Author: Tan EH
Year: 2014
Journal: Oncogene
Title: Functions of TAp63 and p53 in restraining the development of metastatic cancer.
Volume: 33
Issue: 25
Pages: 3325-33
Publication
First Author: Fisher GH
Year: 2001
Journal: Genes Dev
Title: Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.
Volume: 15
Issue: 24
Pages: 3249-62
Publication
First Author: Singh SK
Year: 2015
Journal: EMBO J
Title: Antithetical NFATc1-Sox2 and p53-miR200 signaling networks govern pancreatic cancer cell plasticity.
Volume: 34
Issue: 4
Pages: 517-30
Publication
First Author: Suh YA
Year: 2011
Journal: Cancer Res
Title: Multiple stress signals activate mutant p53 in vivo.
Volume: 71
Issue: 23
Pages: 7168-75
Publication
First Author: Xiong S
Year: 2017
Journal: J Pathol
Title: The p53 inhibitor Mdm4 cooperates with multiple genetic lesions in tumourigenesis.
Volume: 241
Issue: 4
Pages: 501-510
Publication
First Author: Kwon MC
Year: 2013
Journal: Mol Oncol
Title: Mouse models for lung cancer.
Volume: 7
Issue: 2
Pages: 165-77
Publication
First Author: Brichkina A
Year: 2016
Journal: Genes Dev
Title: p38MAPK builds a hyaluronan cancer niche to drive lung tumorigenesis.
Volume: 30
Issue: 23
Pages: 2623-2636
Publication      
First Author: Nakamura T
Year: 2023
Journal: J Pathol
Title: ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathway.
Publication
First Author: Morita M
Year: 2018
Journal: Cancer Cell
Title: PKM1 Confers Metabolic Advantages and Promotes Cell-Autonomous Tumor Cell Growth.
Volume: 33
Issue: 3
Pages: 355-367.e7
Publication
First Author: Rajbhandari N
Year: 2023
Journal: Cancer Cell
Title: Single-cell mapping identifies MSI(+) cells as a common origin for diverse subtypes of pancreatic cancer.
Volume: 41
Issue: 11
Pages: 1989-2005.e9
Publication
First Author: Koikawa K
Year: 2021
Journal: Cell
Title: Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy.
Volume: 184
Issue: 18
Pages: 4753-4771.e27
Publication
First Author: Cortez-Retamozo V
Year: 2013
Journal: Immunity
Title: Angiotensin II drives the production of tumor-promoting macrophages.
Volume: 38
Issue: 2
Pages: 296-308
Publication
First Author: Steele CW
Year: 2016
Journal: Cancer Cell
Title: CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.
Volume: 29
Issue: 6
Pages: 832-845
Publication
First Author: Tan X
Year: 2013
Journal: PLoS One
Title: Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer.
Volume: 8
Issue: 11
Pages: e80885
Publication
First Author: Qu Z
Year: 2015
Journal: Cancer Res
Title: Interleukin-6 Prevents the Initiation but Enhances the Progression of Lung Cancer.
Volume: 75
Issue: 16
Pages: 3209-15